GCG and macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss: Beyond these measures, future controlled trials are necessary to explore the efficacy of GLP-2 therapy in preventing and managing SIBO in pediatric SBS patients.